Alexandria Real Estate Equities
ARE
#2319
Rank
A$11.83 B
Marketcap
A$68.47
Share price
-2.38%
Change (1 day)
-56.16%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Revenue for Alexandria Real Estate Equities (ARE)

Revenue in 2025 (TTM): A$4.65 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current revenue (TTM ) is A$4.48 Billion. In 2024 the company made a revenue of A$4.90 Billion an increase over the revenue in the year 2023 that were of A$4.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alexandria Real Estate Equities from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$4.65 B-5.13%
2024 A$4.90 B17.52%
2023 A$4.17 B10.21%
2022 A$3.78 B30.17%
2021 A$2.90 B19.05%
2020 A$2.44 B12.74%
2019 A$2.16 B16.08%
2018 A$1.86 B29.76%
2017 A$1.43 B15.46%
2016 A$1.24 B10.72%
2015 A$1.12 B27.8%
2014 A$0.88 B26.62%
2013 A$0.69 B20.27%
2012 A$0.57 B18.75%
2011 A$0.48 B7.68%
2010 A$0.45 B4.3%
2009 A$0.43 B-18.22%
2008 A$0.52 B46.89%
2007 A$0.36 B16.38%
2006 A$0.31 B18.57%
2005 A$0.26 B30.95%
2004 A$0.19 B11.72%
2003 A$0.17 B-14.06%
2002 A$0.20 B7.56%
2001 A$0.19 B33.25%
2000 A$0.14 B43.37%
1999 A$0.10 B31.84%
1998 A$76.75 M79.89%
1997 A$42.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
A$94.52 B 2,007.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$43.78 B 876.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$89.45 B 1,894.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$6.45 B 43.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$72.31 B 1,512.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$54.15 B 1,107.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$4.83 B 7.74%๐Ÿ‡บ๐Ÿ‡ธ USA